Omnicell Stock Price, News & Analysis (NASDAQ:OMCL)

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Omnicell, Inc. (NASDAQ:OMCL) released its quarterly earnings data on Thursday, July, 25th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.04. The firm earned $217.40 million during the quarter, compared to the consensus estimate of $214.13 million. Omnicell had a return on equity of 11.85% and a net margin of 5.70%. The firm's quarterly revenue was up 15.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.46 earnings per share. View Omnicell's Earnings History.

Omnicell is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Omnicell.

Omnicell will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Omnicell updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $2.65-$2.82 for the period, compared to the Thomson Reuters consensus estimate of $2.77. The company issued revenue guidance of $886-$900 million, compared to the consensus revenue estimate of $891.96 million.

7 equities research analysts have issued 1-year target prices for Omnicell's shares. Their forecasts range from $61.00 to $90.00. On average, they anticipate Omnicell's share price to reach $80.29 in the next year. This suggests a possible upside of 5.5% from the stock's current price. View Analyst Price Targets for Omnicell.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Omnicell.

Headlines about OMCL stock have trended somewhat positive this week, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Omnicell earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Omnicell.

Some companies that are related to Omnicell include Nice (NICE), CAPCOM CO LTD/ADR (CCOEY), Teradata (TDC), Cray (CRAY), Fitbit (FIT), Super Micro Computer (SMCI), Huami (HMI), One Stop Systems (OSS), CCUR (CCUR) and Socket Mobile (SCKT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), Johnson & Johnson (jnj), Gilead Sciences (GILD), Micron Technology (MU), Paypal (PYPL), AbbVie (ABBV), Adobe (ADBE), Align Technology (ALGN), Netflix (NFLX) and NVIDIA (NVDA).

Omnicell's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Stephens Investment Management Group LLC (0.80%), Tributary Capital Management LLC (0.65%), Peregrine Capital Management LLC (0.65%), Summit Creek Advisors LLC (0.53%), Scout Investments Inc. (0.44%) and Rhenman & Partners Asset Management AB (0.22%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann. View Institutional Ownership Trends for Omnicell.

OMCL stock was sold by a variety of institutional investors in the last quarter, including Pwmco LLC, Scout Investments Inc., Rhenman & Partners Asset Management AB, Tributary Capital Management LLC, Stephens Investment Management Group LLC, CIBC Private Wealth Group LLC and Envestnet Asset Management Inc.. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann. View Insider Buying and Selling for Omnicell.

OMCL stock was bought by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Summit Creek Advisors LLC, Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Assenagon Asset Management S.A., Zurcher Kantonalbank Zurich Cantonalbank , Stephens Inc. AR and West Coast Financial LLC. View Insider Buying and Selling for Omnicell.

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OMCL stock can currently be purchased for approximately $76.07.

Omnicell has a market capitalization of $3.17 billion and generates $787.31 million in revenue each year. The company earns $37.73 million in net income (profit) each year or $1.53 on an earnings per share basis. Omnicell employs 2,480 workers across the globe.View Additional Information About Omnicell.

The official website for Omnicell is http://www.omnicell.com/.

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]